Real Diagnostics Acquires SimplyTest for Oral Health Testing

Real Diagnostics has acquired SimplyTest, expanding its laboratory portfolio into saliva-based oral health diagnostic testing, according to Pulse2. Pulse2 reported that the transaction extends Real Diagnostics’ molecular diagnostic services into oral health testing and establishes a new service offering for dental practices.

Real Diagnostics is a clinical laboratory specializing in high-complexity molecular diagnostics and toxicology testing, Pulse2 said. SimplyTest provides saliva-based oral health diagnostic tests. Through the acquisition, Real Diagnostics adds a new testing area alongside its existing molecular diagnostics and toxicology focus.

Portfolio expands into periodontal health testing

Pulse2 reported that the acquisition expands Real Diagnostics’ laboratory portfolio into periodontal health testing. The reported expansion centers on saliva-based testing for oral health and brings SimplyTest’s diagnostic test offering into Real Diagnostics.

The deal also establishes a service offering for dental practices, according to Pulse2. The publisher characterized the transaction as an expansion of Real Diagnostics’ molecular diagnostic services into saliva-based oral health testing.

Companies bring distinct testing focuses

Real Diagnostics and SimplyTest enter the transaction with different stated areas of focus. Pulse2 identified Real Diagnostics as a clinical laboratory with experience in high-complexity molecular diagnostics and toxicology testing. SimplyTest’s stated offering is saliva-based oral health diagnostic tests.

• Real Diagnostics: A clinical laboratory specializing in high-complexity molecular diagnostics and toxicology testing.
• SimplyTest: A provider of saliva-based oral health diagnostic tests.
• Acquisition result: An expanded laboratory portfolio that includes periodontal health testing and a new offering for dental practices.

Relevance for diagnostics and laboratory sales

For professionals following diagnostics and laboratory activity, the acquisition links a high-complexity molecular diagnostics and toxicology testing laboratory with saliva-based oral health testing. Pulse2 reported that the transaction expands Real Diagnostics’ services into this testing category while adding periodontal health testing to its portfolio.

The announced acquisition is centered on the companies’ respective testing capabilities and the resulting service offering for dental practices. Pulse2’s report identifies saliva-based oral health diagnostics and periodontal health testing as the areas added through the transaction.